Comparison of the Abbott Realtime™ HIV-1 and HCV viral load assays with commercial competitor assays

References

• Mellors JW, Rinaldo CR Jr, Gupta P et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science272(5265), 1167–1170 (1996).
   PubMed Web of Science ®Google Scholar
• van Esser JW, van der HB, Meijer E et al. Epstein–Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV–lymphoproliferative disease following T-cell-depleted SCT. Blood98(4), 972–978 (2001).
   PubMed Web of Science ®Google Scholar
• van Esser JW, Niesters HG, van der Holt B et al. Prevention of Epstein–Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood99(12), 4364–4369 (2002).
   PubMed Web of Science ®Google Scholar
• van der Ende ME, Prins JM, Brinkman K et al. Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients. AIDS17(Suppl. 3), S55–S61 (2003).
   Google Scholar
• Gazzard B, Bernard AJ, Boffito M et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med.7(8), 487–503 (2006).
   PubMed Web of Science ®Google Scholar
• Yee HS, Currie SL, Darling JM, Wright TL. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. Am. J. Gastroenterol.101(10), 2360–2378 (2006).
   PubMed Web of Science ®Google Scholar
• Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm. Rep.55(RR-11), 1–94 (2006).
   PubMedGoogle Scholar
• Abbott MA, Poiesz BJ, Byrne BC et al. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J. Infect. Dis.158(6), 1158–1169 (1988).
   PubMedGoogle Scholar
• Compton J. Nucleic acid sequence-based amplification. Nature350(6313), 91–92 (1991).
   PubMed Web of Science ®Google Scholar
• de Baar MP, van Dooren MW, de Rooij E et al. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O. J. Clin. Microbiol.39(4), 1378–1384 (2001).
   PubMedGoogle Scholar
• Dewar RL, Highbarger HC, Sarmiento MD et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis.170(5), 1172–1179 (1994).
   PubMedGoogle Scholar
• Kwok S, Higuchi R. Avoiding false positives with PCR. Nature339(6221), 237–238 (1989).
   PubMed Web of Science ®Google Scholar
• Schutten M, Peters D, Back NK et al. Multicenter evaluation of the new Abbott Realtime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J. Clin. Microbiol.45(6), 1712–1717 (2007).
   PubMed Web of Science ®Google Scholar
• Schutten M, Niesters HG. Clinical utility of viral quantification as a tool for disease monitoring. Expert Rev. Mol. Diagn.1(2), 153–162 (2001).
   PubMedGoogle Scholar
• Beuselinck K, Van Ranst M, van Eldere J. Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR. J. Clin. Microbiol.43(11), 5541–5546 (2005).
   PubMedGoogle Scholar
• Sabato MF, Shiffman ML, Langley MR, Wilkinson DS, Ferreira-Gonzalez A. Comparison of the performance characteristics of three real-time RT-PCR test systems for detection and quantification of hepatitis C virus. J. Clin. Microbiol.45(8), 2529–2536 (2007).
   PubMedGoogle Scholar
• Highbarger HC, Hu Z, Kottilil S et al. Comparison of the Abbott 7000 and Bayer 340 systems for measurement of hepatitis C virus load. J. Clin. Microbiol.45(9), 2808–2812 (2007).
   PubMedGoogle Scholar
• Colucci G, Ferguson J, Harkleroad C et al. Improved COBAS Taqman hepatitis C virus test (version 2.0) for use with the High Pure System: enhanced genotype inclusivity and performance characteristics in a multiside study. J. Clin. Microbiol.45(11), 3595–3600 (2007).
   PubMed Web of Science ®Google Scholar
• Luk KC, Devare SG, Hackett JR Jr. Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets. J. Virol. Methods144(1–2), 1–11 (2007).
   PubMedGoogle Scholar
• Huang S, Salituro J, Tang N et al. Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Res.35(16), E101–E108 (2007).
   PubMed Web of Science ®Google Scholar
• Swanson P, de Mendoza C, Joshi Y et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol.43(8), 3860–3868 (2005).
   PubMed Web of Science ®Google Scholar
• Gao G, Buskell Z, Seeff L, Tabor E. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. J. Med. Virol.68(1), 60–67 (2002).
   PubMedGoogle Scholar
• Swanson P, Huang S, Holzmayer V et al. Performance of the automated Abbott Realtime HIV-1 assay on a genetically diverse panel of specimens from Brazil. J. Virol. Methods134(1–2), 237–243 (2006).
   PubMedGoogle Scholar
• Swanson P, Holzmayer V, Huang S et al. Performance of the automated Abbott Realtime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. J. Virol. Methods137(2), 184–192 (2006).
   PubMed Web of Science ®Google Scholar
• Swanson P, Huang S, Abravaya K et al. Evaluation of performance across the dynamic range of the Abbott Realtime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. J. Virol. Methods141(1), 49–57 (2007).
   PubMed Web of Science ®Google Scholar
• Tang N, Huang S, Salituro J et al. A Realtime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A–H, group O and group N samples. J. Virol. Methods146(1–2), 236–245 (2007).
   PubMed Web of Science ®Google Scholar
• Garcia-Diaz A, Clewley GS, Booth CL et al. Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation. J. Clin. Microbiol.44(5), 1788–1791 (2006).
   PubMed Web of Science ®Google Scholar
• Gueudin M, Plantier JC, Lemee V et al. Evaluation of the Roche Cobas TaqMan and Abbott Realtime extraction–quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr.44(5), 500–505 (2007).
   PubMed Web of Science ®Google Scholar
• Michelin BD, Muller Z, Stelzl E, Marth E, Kessler HH. Evaluation of the Abbott Realtime HCV assay for quantitative detection of hepatitis C virus RNA. J. Clin. Virol.38(2), 96–100 (2007).
   PubMedGoogle Scholar
• Schutten M, Fries E, Burghoorn-Maas C, Niesters HG. Evaluation of the analytical performance of the new Abbott Realtime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA. J. Clin. Virol.40(2), 99–104 (2007).
   PubMed Web of Science ®Google Scholar
• Tuaillon E, Mondain AM, Ottomani L et al. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV Realtime assay [corrected] and VERSANT HCV RNA assay. J. Clin. Microbiol.45(9), 3077–3081 (2007).
   PubMedGoogle Scholar
• Wolff D, Gerritzen A. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott Realtime test assays for quantification of hepatitis C virus and HIV RNA. Clin. Chem. Lab Med.45(7), 917–922 (2007).
   PubMedGoogle Scholar
• Fytili P, Tiemann C, Wang C et al. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay. J. Clin. Virol.39(4), 308–311 (2007).
   PubMed Web of Science ®Google Scholar
• Muller J, Eis-Hubinger AM, Daumer M et al. A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region. J. Virol. Methods142(1–2), 127–135 (2007).
   PubMedGoogle Scholar
• Braun P, Ehret R, Wiesmann F et al. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin. Chem. Lab. Med.45(1), 93–99 (2007).
   PubMed Web of Science ®Google Scholar
• Halfon P, Bourliere M, Penaranda G, Khiri H, Ouzan D. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J. Clin. Microbiol.44(7), 2507–2511 (2006).
   PubMed Web of Science ®Google Scholar
• Damond F, Roquebert B, Benard A et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol.45(10), 3436–3438 (2007).
   PubMed Web of Science ®Google Scholar
• Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology46(1), 22–31 (2007).
   PubMed Web of Science ®Google Scholar
• Wiedmann M, Kluwick S, Walter M et al. HIV-1, HCV and HBV seronegative window reduction by the new Roche Cobas TaqScreen MPX test in seroconverting donors. J. Clin. Virol.39(4), 282–287 (2007).
   PubMed Web of Science ®Google Scholar
• Abbott RealTime™ HCV, package insert. Abbott Molecular, Inc., IL, USA.
   Google Scholar
• Abbott RealTime™ HIV-1, Abbott Molecular, Inc., IL, USA.
   Google Scholar